[Impulsivity in adolescents with attention deficit hyperactivity disorder].

Area of Science:

• Neuroscience
• Child and Adolescent Psychiatry
• Pharmacology

Background:

• Attention Deficit Hyperactivity Disorder (ADHD) is prevalent in adolescents.
• Impulsivity and anxiety are heightened in ADHD, particularly in the hyperactive subtype.
• Limited treatment options exist for managing impulsivity in adolescent ADHD.

Purpose of the Study:

• To investigate impulsivity in adolescents diagnosed with ADHD.
• To evaluate the efficacy of noophen (500 mg daily for 45 days) in treating ADHD-related impulsivity.
• To compare clinical presentations between ADHD predominantly hyperactive and combined types.

Main Methods:

• Clinical, psychological, and psycho-physiological assessments were conducted on 60 adolescents (aged 12-15) with ADHD.
• Comparative analysis of ADHD subtypes (predominantly hyperactive vs. combined).
• Evaluation of noophen's therapeutic effect on impulsivity and anxiety levels.

Main Results:

• Adolescents with ADHD predominantly hyperactive type exhibited significantly higher anxiety and impulsivity.
• Noophen treatment demonstrated high clinical efficacy.
• Sixty-three point three percent of patients showed improvement after 45 days of noophen therapy.

Conclusions:

• Noophen is a clinically effective treatment for impulsivity in adolescents with ADHD.
• The study supports the use of noophen for improving ADHD symptoms, particularly impulsivity.
• Further research may explore noophen's impact on specific ADHD subtypes.